Nasopharyngeal cancer patients with lymphatic metastasis and bone metastasis can be treated with chemotherapy, radiotherapy or targeted drug therapy to control the continuous spread of cancer cells, alleviate symptoms and prolong the survival period. Chemotherapeutic drugs commonly used in treating lymphatic metastasis of nasopharyngeal cancer include cisplatin and paclitaxel, etc. They can be used together with radiotherapy to kill the residual tumor cells in the local area, control the continuous spread of cancer cells and reduce the occurrence of distant metastasis. Most of nasopharyngeal carcinomas are low-differentiated squamous carcinomas, which are sensitive to radiotherapy, therefore, radiotherapy is the first choice, followed by chemotherapy or surgery. If lymphatic metastasis or bone metastasis occurs, it has generally survived. Nasopharyngeal cancer with lymphatic metastasis and bone metastasis, it is recommended to go to formal treatment to control the spread of cancer cells and prolong the survival period through chemotherapy, radiotherapy and targeted therapy when it reaches middle or late stage.